SCHEMBL18267705

SCHEMBL18267705

c1ccc(-c2cccc(-c3ccc(N(c4ccccc4)c4ccc5c(ccc6ccc7c8ccccc8oc7c65)c4)cc3)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.37
▸ PLA2G4A P47712 3/20 0.37
▸ ALOX5 P09917 3/20 0.36
▸ PLA2G10 O15496 1/20 0.35
▸ CYP19A1 P11511 1/20 0.33
▸ AHR P35869 2/20 0.33
▸ JAK2 O60674 1/20 0.32
▸ ZAP70 P43403 1/20 0.32
▸ SYK P43405 1/20 0.32
▸ CYP1A1 P04798 3/20 0.32
▸ CYP1A2 P05177 3/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ FYN P06241 1/20 0.32
▸ MAPK3 P27361 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ ABCG2 Q9UNQ0 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ CYP1B1 Q16678 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18267704 0.99 PLA2G2A (0.38) PLA2G2APLA2G4AALOX5PLA2G10CYP19A1
SCHEMBL18267556 0.99 PLA2G2A (0.38) PLA2G2APLA2G4AALOX5PLA2G10CYP19A1
SCHEMBL18267555 0.98 ALOX5 (0.36) PLA2G2APLA2G4AALOX5PLA2G10CYP19A1
SCHEMBL18267655 0.96 ALOX5 (0.37) PLA2G2APLA2G4AALOX5PLA2G10CYP19A1
SCHEMBL18267656 0.96 ALOX5 (0.34) PLA2G2APLA2G4AALOX5PLA2G10CYP19A1
SCHEMBL18267545 0.96 ALOX5 (0.36) PLA2G2APLA2G4AALOX5CYP19A1AHR
SCHEMBL18267703 0.96 ALOX5 (0.36) PLA2G2APLA2G4AALOX5CYP19A1AHR
SCHEMBL18267652 0.95 ALOX5 (0.36) PLA2G2APLA2G4AALOX5PLA2G10CYP19A1
SCHEMBL18267659 0.95 ALOX5 (0.36) PLA2G2APLA2G4AALOX5PLA2G10CYP19A1
SCHEMBL18267619 0.95 ALOX5 (0.36) PLA2G2APLA2G4AALOX5CYP19A1AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446760-B2 Organic compound, organic optoelectric diode, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 — — US disclosed
US-20160351820-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-12-01 — — US disclosed
US-20160351820-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446760-B2 Organic compound, organic optoelectric diode, and display device OCIAD1, OXER1, OR10J3 PLA2G2A 4691/4885PLA2G4A 4573/4885ALOX5 527/4885
US-20160351820-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRIC DIODE, AND DISPLAY DEVICE OCIAD1, OXER1, OR10J3 PLA2G2A 4691/4885PLA2G4A 4573/4885ALOX5 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback